Showing 3921-3930 of 4063 results for "".
- Health Burden of Glaucoma Has Risen Worldwidehttps://modernod.com/news/health-burden-of-glaucoma-has-risen-worldwide/2476271/The health burden of glaucoma has continuously increased around the globe in the past 25 years, according to an Acta Opthalmologica study. Higher burdens were associat
- Allergan Responds to Public Shareholder Letterhttps://modernod.com/news/allergan-responds-to-public-shareholder-letter/2476274/Allergan issued the following statement from its Board of Directors in response to a public shareholder letter from Appaloosa hedge fund manager David Tepper earlier this week that stated the drugmaker should consider a merger or selling itself if it is “unable or unwilling to hold manageme
- RightEye Introduces Functional Vision EyeQ Automated Testhttps://modernod.com/news/righteye-introduces-functional-vision-eyeq-automated-test/2476278/RightEye announced the launch of Functional Vision EyeQ, a first-of-its kind automated test that allows optometrists to quickly and objectively identify functional vision issues that affect a host of everyday activiti
- Alcon Debuts iLux MGD Treatment System at SECOhttps://modernod.com/news/alcon-debuts-ilux-mgd-treatment-system-for-personalized-therapy-for-dry-eye-disease-at-seco/2476284/Alcon debuted the iLux MGD Treatment System at the SECO International 2019 annual meeting in New Orleans. The device, which received approval from the FDA in December 2017, helps eye care professionals provide comprehensive, in-office
- MacuLogix Relocates to Larger Headquarters in Harrisburg, Pennsylvania to Accommodate Growthhttps://modernod.com/news/maculogix-relocates-to-larger-headquarters-in-harrisburg-pennsylvania-to-accommodate-growth/2476286/MacuLogix relocated its headquarters from Middletown, PA, to Harrisburg as the company has grown from 12 to 65 employees in the past 3 years, including 25 home office employees supporting its national field-based sale
- UnitedHealthcare Vision Plans Rank Highest in Customer Satisfaction in J.D. Power Reporthttps://modernod.com/news/unitedhealthcare-vision-plans-rank-highest-in-customer-satisfaction-in-j-d-power-report/2476287/UnitedHealthcare Vision plans tied for highest in customer satisfaction among the nation’s vision carriers, according to the J.D. Power 2018 Vision Plan Satisfaction Report. This marks the fifth time in 6 years that UnitedHealthcare Vision has earned the highest ranking among vision plans.
- Registration Now Open for Neuro-Optometric Rehabilitation Association Meetinghttps://modernod.com/news/registration-now-open-for-neuro-optometric-rehabilitation-association-meeting/2476291/Registration is now open for the Neuro-Optometric Rehabilitation Association, International (NORA) Clinical Skills Pre-Conference (September 19-20) and 28th annual General Conference (September 21-22) at the Embassy Suites by Hilton Scottsdale Resorts, Scottsdale, Arizona. The
- New Medscape Report Finds More Than One in Three Doctors are Burned Outhttps://modernod.com/news/new-medscape-report-finds-more-than-one-in-three-doctors-are-burned-out/2476292/Burnout and depression are having a significant effect on the global medical community, as demonstrated by Medscape’s Global Physicians’ Burnout and Lifestyle Comparisons report. Nearly 20,000 doctors in six countries (France,
- Heidelberg OCT2 Module Successfully Installed at the International Space Stationhttps://modernod.com/news/heidelberg-oct2-module-successfully-installed-at-the-international-space-station/2476295/Heidelberg Engineering announced that its Spectralis imaging platform with the company’s next-generation OCT2 Module has been successfully installed at the International Space Station (ISS) and is now fully operational. NASA launched the Spectralis with OCT2 Module to the ISS aboard the An
- Melt Pharmaceuticals Improves Patent Estate for Sublingual Non-Opioid Pain and Sedation Formulationshttps://modernod.com/news/melt-pharmaceuticals-improves-patent-estate-for-sublingual-non-opioid-pain-and-sedation-formulations/2476298/Melt Pharmaceuticals, a specialty pharmaceutical company recently deconsolidated from Harrow Health, announced the U.S. Patent and Trademark office has issued two additional patents covering the company’s innovative sublingual, non-opioid pain and sedation formulations. U.S. Patents 10,16